Why Closing Lung Cancer’s Diagnostic Gap Will Require New Lab Strategies
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read MorePosted by Alyx Arnett | Sep 25, 2025 | Lung Cancer |
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read MorePosted by CLP Edit Staff | Sep 25, 2025 | Unknown Origin & Other Cancer Types |
The laboratory-developed test is used to detect and monitor metastatic central nervous system cancer.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Lung Cancer |
The 2,400-patient study evaluates the Percepta Nasal Swab test’s ability to guide management decisions for patients with lung nodules.
Read MorePosted by CLP Edit Staff | Sep 22, 2025 | Lung Cancer |
Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.
Read MorePosted by CLP Edit Staff | Sep 17, 2025 | Tuberculosis |
The test showed 74% detection rate in tongue swabs compared to 56% with traditional testing methods that rely on difficult-to-collect sputum samples.
Read More